Quantcast
Home > Quotes > RVP

Retractable Technologies, Inc. Common Stock (RVP) Quote & Summary Data

RVP 
$0.84
*  
0.059
7.55%
Get RVP Alerts
*Delayed - data as of Mar. 19, 2019 10:58 ET  -  Find a broker to begin trading RVP now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    RVP Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
Today's High / Low
$ 0.9401 / $ 0.81
Share Volume
113,540
90 Day Avg. Daily Volume
96,278
Previous Close
$ 0.781
52 Week High / Low
$ 1.34 / $ 0.541
Market Cap
27,439,821
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.34

Intraday Chart

Shares Traded

Share Volume:
113,540
90 Day Avg. Daily Volume:
96,278

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.09

Trading Range

The current last sale of $0.84 is 55.27% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.9401 $ 1.34
 Low: $ 0.81 $ 0.541

Company Description (as filed with the SEC)

Retractable Technologies, Inc. was incorporated in Texas in 1994. Our business is the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. We have manufacturing facilities in Little Elm, Texas and use manufacturers in China as well. We have developed several new products in the last few years, including the EasyPoint┬« needle which can be used with, among other things, prefilled syringes. In 2007, we filed a lawsuit claiming that we have been blocked from gaining market access due to actions taken by BD. In August 2017, a district court dismissed our remaining claims against BD and entered a take nothing judgment. We have filed for appeal. Financial Information We do not report in segments. See Item 8 for our financial statements. Principal Products, Markets, and Distribution Our goal is to become a leading provider of safety medical products.  ... More ...  



Research Brokers before you trade

Want to trade FX?

Analyst Info